The story of Viagra and its impact on the healthcare landscape presents a thorny question for shareholders . Initially a blockbuster drug, competitors have significantly eroded its knockoff market share , creating obstacles for companies connected to the original patent holder and related advancements . While certain firms might benefit from focuse